Related Experiment Video
Updated: Apr 21, 2026
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening
Ki-Hwan Nam1, Alec S T Smith2, Saifullah Lone3
1Department of Bioengineering, University of Washington, Seattle, WA, USA Department of Electrical and Computer Engineering, Seoul National University, Seoul, Republic of Korea Center for Analytical Instrumentation Development, The Korea Basic Science Institute, Deajeon, Republic of Korea.
Current 2D drug screening models fail to replicate human tissue complexity. Microengineered 3D tissue models offer superior preclinical testing by better mimicking in vivo environments for improved drug efficacy prediction.
Area of Science:
- Biomedical Engineering
- Drug Discovery
- Tissue Engineering
Background:
- Current 2D cell-based assays inadequately represent in vivo human tissue complexity.
- This limitation leads to inaccurate preclinical predictions of drug compound effects on tissue functionality.
- Simplistic 2D models struggle with long-term cell culture and single-target screening, further compromising physiological relevance.
Purpose of the Study:
- To review the development of microengineered 3D tissue models for drug screening.
- To highlight the advantages of 3D microtissue models over conventional 2D assays.
- To discuss biomimetic 3D environments for predictive preclinical drug screening.
Main Methods:
- Review of literature on microengineered 3D tissue models.
- Comparison of 2D versus 3D cell culture systems for drug screening.
- Discussion of biomimetic engineering principles for tissue models.
Main Results:
- 3D cell cultures demonstrate improved in vivo tissue functionality modeling compared to 2D cultures.
- Microengineered 3D tissue models accurately mimic native tissue physiological properties.
- 3D microtissue models offer enhanced advantages for preclinical drug screening applications.
Conclusions:
- Microengineered 3D tissue models provide a more physiologically relevant platform for drug screening.
- These advanced models improve the accuracy of predicting compound efficacy.
- Biomimetic 3D environments are crucial for developing more predictive preclinical drug screening assays.
